Anshul Maheshwari was named Chief Operating Officer of SI-BONE, Inc., effective February 22, 2026. As of November 14, 2026, SI-BONE, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 23, 2026, naming 1 appointment (Form 8-K, February 23, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like SI-BONE, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
SI-BONE, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-23. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as SI-BONE, Inc. files it.
Also on the record for SI-BONE, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by BROWN ADVISORY INC | 4.52% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by Cadian Capital Management, LP | 7.5% of the class | 5%+ stakes | Source |
| July 30, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 8% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13G/A, by Mathew P. Arens | 18.36% of the class | 5%+ stakes | Source |
| April 24, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.9% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by OrbiMed Capital LLC | — | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by American Century Investment Management, Inc. | 5.3% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by BROWN ADVISORY INC | 5.79% of the class | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G, by Champlain Investment Partners, LLC | 4.9% of the class | 5%+ stakes | Source |
| December 5, 2025 | Stake report, Schedule 13G, by Mathew P. Arens | 11.92% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by American Century Investment Management, Inc. | 6.6% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs SI-BONE, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on SI-BONE, Inc. and the records around it.
SI-BONE, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Champlain Investment Partners, LLC also filed stake reports on 6 other companies: Baldwin Insurance Group, Inc. (Feb 2026), Freshpet, Inc. (Feb 2026), OneStream, Inc. (Feb 2026)
- Cadian Capital Management, LP also filed stake reports on 7 other companies: Cryoport, Inc. (Aug 2026), Flywire Corp. (Aug 2026), TACTILE SYSTEMS TECHNOLOGY INC (Aug 2026)
- First Light Asset Management, LLC also filed stake reports on 12 other companies: NeuroPace Inc (Sep 2026), Neogenomics, Inc. (Aug 2026), PALVELLA THERAPEUTICS, INC. (Aug 2026)
Watch SI-BONE, Inc.
Get an email when SI-BONE, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on SI-BONE, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SI-BONE, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SI-BONE, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 14 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-02-23 | In | Chief Operating Officer | 2026-02-22 | 8-K, 2026-02-23 |
Who leads SI-BONE, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Operating Officer: Anshul Maheshwari, appointed, effective 2026-02-22 (filed 2026-02-23).
New leaders reset buying decisions — get the Full Report on SI-BONE, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Operating Officer at SI-BONE, Inc., with the record behind each one.
Find candidates like Chief Operating Officer at SI-BONE, Inc.Every change, in the filing's words
Appointed: Anshul Maheshwari, Chief Operating Officer, effective 2026-02-22
On February 22, 2026, the Company appointed Anshul Maheshwari, the Company's Chief Financial Officer, also as the Company's Chief Operating Officer, effective February 22, 2026.
- Mr. Maheshwari, age 46, has served as the Company's Chief Financial Officer since April 2021.
- Prior to joining the Company, Mr. Maheshwari served as Vice President of Finance and Treasurer from June 2018 and Head of Investor Relations from October 2019 for Varian Medical Systems ("Varian"), a cancer care company, until its acquisition by Siemens Healthineers AG in April 2021.
- At Varian, he was responsible for treasury and risk management, capital markets, customer finance, financial and strategic planning and investor relations.
- From April 2013 to June 2014, Mr. Maheshwari served as Manager of Investments and from June 2014 to June 2018, served as Assistant Treasurer for Bechtel Corporation, an engineering and construction company, in which latter roles he was responsible for managing global treasury operations.
- From November 2004 to March 2013, Mr. Maheshwari served in various client facing roles within the corporate and investment bank divisions at Bank of America Merrill Lynch.
- Mr. Maheshwari received a M.B.A. from Boston College, Carroll Graduate School of Management and a Bachelors of Commerce from the H.R. College of Commerce in India.
Tools for this story
Each opens in a new tab, filled in for SI-BONE, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
